United Therapeutics(UTHR.US) Officer Sells US$1.83 Million in Common Stock

$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 7,200 shares of common stock on May 1, 2, 2024 at an average price of $254.1532 for a total value of $1.83 million.Source: Announcement

Futu NewsMay 4 05:15

United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on May 01, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,829,903. Following the Form 4 filing with the SEC, Rothblatt has control over

MT NewswiresMay 4 04:39

Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 582.2K in Common Stocks

SEC FILLINGS DISCLOSED/ May 3, $United Therapeutics(UTHR.US)$ Director CHRISTOPHER CAUSEY intends to sell 2,240 shares of its common stock on May 3, with a total market value of approximately $582.2K.

Futu NewsMay 4 04:23

Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 2.59 Million in Common Stocks

SEC FILLINGS DISCLOSED/ May 3, $United Therapeutics(UTHR.US)$ Director JUDY OLIAN intends to sell 10,000 shares of its common stock on May 3, with a total market value of approximately $2.59 million.

Futu NewsMay 4 04:21

Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 1.33 Million in Common Stocks

SEC FILLINGS DISCLOSED/ May 3, $United Therapeutics(UTHR.US)$ Director LOUIS W. SULLIVAN intends to sell 5,160 shares of its common stock on May 3, with a total market value of approximately $1.33 mil

Futu NewsMay 4 04:08

United Therapeutics Is Maintained at Neutral by Goldman Sachs

United Therapeutics Is Maintained at Neutral by Goldman Sachs

Dow JonesMay 4 00:13